Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Dramatic Response of BRAF V600E Mutant Papillary Craniopharyngioma to Targeted Therapy.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Dramatic Response of BRAF V600E Mutant Papillary Craniopharyngioma to Targeted Therapy.
Dramatic Response of BRAF V600E Mutant Papillary Craniopharyngioma to Targeted Therapy. J Natl Cancer Inst. 2016 Feb; 108(2).
View in:
PubMed
subject areas
Adult
Adult
Antineoplastic Combined Chemotherapy Protocols
Antineoplastic Combined Chemotherapy Protocols
Craniopharyngioma
Craniopharyngioma
Craniotomy
Craniotomy
Cytoreduction Surgical Procedures
Cytoreduction Surgical Procedures
Drug Administration Schedule
Drug Administration Schedule
Glutamic Acid
Glutamic Acid
Humans
Humans
Imidazoles
Imidazoles
Magnetic Resonance Imaging
Magnetic Resonance Imaging
Male
Male
Molecular Targeted Therapy
Molecular Targeted Therapy
Mutation
Mutation
Neoplasm Recurrence, Local
Neoplasm Recurrence, Local
Neoplasm, Residual
Neoplasm, Residual
Oximes
Oximes
Pituitary Neoplasms
Pituitary Neoplasms
Protein Kinase Inhibitors
Protein Kinase Inhibitors
Proto-Oncogene Proteins B-raf
Proto-Oncogene Proteins B-raf
Pyridones
Pyridones
Pyrimidinones
Pyrimidinones
Treatment Outcome
Treatment Outcome
Valine
Valine
authors with profiles
Ian F Dunn